Wellstone Retains Key Tobacco Chemist

Wellstone Retains Key Tobacco Chemist 


DURHAM, N.C., Nov. 29  /PRNewswire-FirstCall/ -- Wellstone Filters (OTC:WLSF)
(BULLETIN BOARD: WLSF)  announced today that it has retained Dr. John H.
Lauterbach, Ph.D., DABT, FAIC, FRSC, Certified Toxicologist, Certified
Professional Chemist, Chartered Scientist and Chartered Chemist as a consultant
and Wellstone's Chief Scientific Advisor.

Wellstone believes that the addition of Dr. Lauterbach will assist Wellstone to
further develop its formulation, to communicating its technology to other
manufacturers and will be essential in negotiating on Wellstone's behalf.

Dr. Lauterbach recently retired after twenty-four years with the Research &
Development Department at Brown & Williamson Tobacco Corporation.

During his tenure at B&W, Dr. Lauterbach served as Principal Scientist in
Scientific & Regulator Affairs and Director, Research Services.  From 1993 to
1998, he also served as Chairman of the Board of the Tobacco Institute Testing
Laboratory and Chairman of the US Technical Advisory Committee to ISO Technical
Committee TC126 on Tobacco and Tobacco Products.  Dr. Lauterbach is a frequent
presenter at the annual Tobacco Science Research Conferences and is author or
co-author on numerous presentations and journal articles on tobacco science and
toxicology.

Wellstone believes that its patented filter formulation removes tars and
certain carcinogens, while providing better taste. However, any claim as to the
benefit of any Wellstone cigarettes to be sold will be made within the
parameters prescribed by the Federal Trade Commission. Wellstone emphasizes
that NO cigarette is safe. This corporate communication by Wellstone is not
intended to induce any person to purchase future Wellstone tobacco products.

ABOUT THE COMPANY

Wellstone Filters, Inc. has developed and patented filter material that removes
certain carcinogens and other toxins produced when tobacco is smoked -- without
removing the compounds thought to be associated with the pleasurable effects of
smoking. Wellstone seeks to promote material for cigarette filters that will
enable major cigarette manufacturers to provide consumers with an equally
enjoyable cigarette with substantially fewer carcinogens.

For more information, please see http://www.wellstonefilters.com/ or call
Investor relations at 303-620-9194.

In addition, all current shareholders, and interested parties should sign into
our private Corporate Guest Book, http://www.corporateguestbook.com/?WLSF to
receive timely updates and information on any future developments as they
happen.

Note: Except for the historical information contained herein, this new release
contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, supply capabilities and reliance on third-
party manufacturers, product commercialization, competition, litigation, and
the other risk factors listed from time to time in reports filed by Wellstone
with the Securities and Exchange Commission, including but not limited to risks
described under the caption "Important Factors That May Affect Our Business,
Our Results of Operation and Our Stock Price." The forward-looking statements
contained in this news release represent judgments of the management of
Wellstone as of the date of this release. Wellstone and its managers and agents
undertake no obligation to publicly update any forward- looking statements. 

DATASOURCE: Wellstone Filters



CONTACT:  Wellstone Filters Investor relations, [phone]



Web site:  http://www.lowertar.com/

http://www.wellstonefilters.com/

http://www.corporateguestbook.com/ 

Copyright